Teladoc Health launches new virtual healthcare service

A telehealth company has launched a new global service that provides people traveling around the world with access to medical care "regardless of geographic location.”

Teladoc Health announced the launch of its Teladoc Global Care service on Thursday, Sept. 20. The service allows people to have access to a physician that speaks their language and local healthcare services when they are abroad.

"The addition of Teladoc Global Care services enables multinational organizations to provide expats and travelers with a single solution for convenient and easy-to-navigate access to quality care, regardless of geographic location," a press release stated. 

The service is available 24/7 through the Teladoc Health app and includes more than 20 languages including English, Spanish, Portuguese, French, Hungarian, Polish, Mandarin, Cantonese, Korean, Thai, Malay, Hindi, Japanese and Arabic.

The service is commercially available for multinational employers and insurers, according to the release.

“Navigating an unfamiliar health system while traveling heightens uncertainty and stress for employees and can result in higher costs for plan sponsors,” Dan Trencher, Teladoc Health senior vice president of product and corporate strategy, said in a statement.

“With the introduction of Global Care, Teladoc Health is transforming how people access and experience healthcare around the world, and successfully accelerating the pace of innovation with truly differentiated virtual care offerings.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.